Medifast, Inc. (MED)

Market Cap	136.93M
Revenue (ttm)	543.45M
Net Income (ttm)	-7.00M
Shares Out	10.34M
EPS (ttm)	-0.64
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	179,401
Open	13.51
Previous Close	13.44
Day's Range	13.18 - 13.63
52-Week Range	11.57 - 22.66
Beta	0.89
Analysts	Hold
Price Target	16.50 (+24.62%)
Earnings Date	Aug 4, 2025

About MED

Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions to address obesity and support a healthy life in the United States. The company offers weight loss and weight management plans; and GLP-1 support plans that provide access to GLP-1 medications where clinically appropriate under the OPTAVIA brand name. It also provides bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and sou...

• Industry: Personal Services
• Sector: Consumer Discretionary
• Founded: 1980
• Employees: 504
• Stock Exchange: NYSE
• Ticker Symbol: MED
• Website: https://medifastinc.com

Financial Performance

In 2024, Medifast's revenue was $602.46 million, a decrease of -43.80% compared to the previous year's $1.07 billion. Earnings were $2.09 million, a decrease of -97.90%.

Analyst Summary

According to one analyst, the rating for MED stock is "Hold" and the 12-month stock price target is $16.5.

Price Target

$16.5

(24.62% upside)

Analyst Consensus: Hold